Policy brief: Changing the cotrimoxazole prophylaxis guidelines for HIV exposed uninfected infants

Daniels, BSpooner, EMoodley-Govender, EHulol, HGoga, ACoutsoudis, A2025-01-092025-01-092020-10Daniels B, Spooner E, Moodley-Govender EH, H. , Goga A, Coutsoudis A. Policy brief: changing the cotrimoxazole prophylaxis guidelines for HIV exposed uninfected infants - South African evidence. 2020 October.https://www.samrc.ac.za/sites/default/files/attachments/2022-09/CTXPolicyBrief.pdfhttps://hdl.handle.net/11288/598081The World Health Organization (WHO) guidelines recommend that all HIV-exposed infants, including HIV-exposed uninfected infants (HEUs), born to HIV positive mothers receive cotrimoxazole (CTX) prophylaxis, commencing at 4–6 weeks of age and continued until HIV infection can be excluded.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Policy BriefCotrimoxazoleProphylaxisGuidelines for HIV exposed uninfected infantsCotrimoxazole prophylaxis policy briefHIV exposed infantsInfantsMorbidityMortalityHIV positive childrenPolicy brief: Changing the cotrimoxazole prophylaxis guidelines for HIV exposed uninfected infants - South African evidenceTechnical Report